GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
22 hedge funds and large institutions have $8.79M invested in Amplify Treatments, Testing and Advancements ETF in 2021 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.78M | |
| 2 | +$488K | |
| 3 | +$423K | |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$237K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$123K |
Top Sellers
| 1 | -$231K | |
| 2 | -$74.6K | |
| 3 | -$35K | |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$31K |
| 5 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
-$31K |